: In human epidermal growth factor receptor 2 (HER2+) expressing breast cancer subtype, the incidence of brain metastases is common and patients often die due to uncontrolled cranial disease. This is a case report of a HER2+ breast cancer woman with diffuse brain metastases that experienced long survival and clinical benefit from multiple radiotherapy treatments and combined systemic therapy, without increased toxicity.
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report / Silipigni, Sonia; Ippolito, Edy; Matteucci, Paolo; Santo, Bianca; Gangemi, Emma; La Cesa, Annalisa; Santini, Daniele; Greco, Carlo; Ramella, Sara. - In: THE BREAST JOURNAL. - ISSN 1524-4741. - 26:7(2020), pp. 1370-1371. [10.1111/tbj.13844]
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report
Gangemi, Emma;Santini, Daniele;
2020
Abstract
: In human epidermal growth factor receptor 2 (HER2+) expressing breast cancer subtype, the incidence of brain metastases is common and patients often die due to uncontrolled cranial disease. This is a case report of a HER2+ breast cancer woman with diffuse brain metastases that experienced long survival and clinical benefit from multiple radiotherapy treatments and combined systemic therapy, without increased toxicity.| File | Dimensione | Formato | |
|---|---|---|---|
|
12. Silipigni_metastasi da breast cancer_TBJ2020_Aprile.pdf
accesso aperto
Note: Silipigni_Repeated courses_2020
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
201.65 kB
Formato
Adobe PDF
|
201.65 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
